Bio Buyside Analyst | Stocks | Options | CFA | Opinion/speculation only & not advice/solicitation | May be L/S names, do your own diligence, consider conflictsJoined February 2021
43 Followers 1K Following👑 Stock Market for Biotech Royalties 👑 | Unlocking a New Asset Class | 📩 DM for a free royalties whitepaper | https://t.co/hSsMNYi0Mm
118 Followers 875 Following@Gates_Cambridge MB/PhD Candidate @GurdonInstitute | Cancer epigenetics and therapeutics - @TKLabUK | Oncology | Public Health
72 Followers 309 FollowingMPhil at @Cambridge_Uni | Former RA at @DanaFarber | Weinberg lab @WhiteheadInst alum | Background in cancer, stem cell, and developmental biology research.
1K Followers 7K FollowingBe informed Use our DropBox 🔑
If you want to understand the market better or need materials for writing articles
https://t.co/m0q9nKWLzQ
36 Followers 173 FollowingBiotech professional for @LifeSciAdvisors. Running investor network providing access to management teams. Not financial advice.
328 Followers 790 FollowingThe question is not "what can I do with my money? but "what can my money do for me?"! Independent Financial Planner, helping people live more.
2K Followers 118 FollowingPhysician, bio/med tech and tech enthusiast, nothing I say is financial advice , just a long term investor in high growth stocks with personal opinions
21K Followers 2K FollowingThe International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
2K Followers 332 FollowingaTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways.
1K Followers 0 FollowingWatch for copy cats. We do not ever ask to invest your money. We post simple analytics within smaller cap bio/pharma for entertainment purposes only.
15K Followers 292 FollowingHedge fund mgr. Not financial advice. Happy to debate ideas, especially shorts. River Road Partners is a made-up name for X, by the way, so don’t bother.
1K Followers 625 FollowingDiaMedica Therapeutics (Nasdaq:DMAC) is a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases $DMAC
241K Followers 221 FollowingWe advance science so that we all have more time with the people we love.
Read our community guidelines: https://t.co/7k1HdbdrYL
106K Followers 6K FollowingI Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech
1K Followers 340 FollowingI tweet a lot about mostly nothing. I don't accept new followers. It's nothing personal, the world is a cesspool. Public videos on YT @given2trade4
3K Followers 171 FollowingPart-time $XBI investor since 2020 (Long only). My opinions are my own and are not investment recommendations. I buy/sell without disclosures.
8K Followers 4K FollowingAt the intersection of #AI & #Oncology data. We provide clinical intelligence, trial insights & competitive analysis for #Pharmaceutical & #BioTech.
628 Followers 164 FollowingTarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients starting with the eye
10K Followers 399 FollowingBiotech Sell side analyst at @rwbaird. Probability of a false positive = 1 - (1 - alpha value)^n. De omnibus dubitandum est. Inventor of 𝕊𝕒𝕣𝕔𝕒𝕤𝕞 𝔽𝕠𝕟𝕥
7K Followers 447 FollowingFormer M&A and Markets Editor at The Daily Telegraph. Now a freelance journalist looking for work! Editor of Betaville - https://t.co/VW5FHAgZ2B
6K Followers 2K FollowingNo investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold
3K Followers 58 FollowingTG is a biopharmaceutical company focused on the acquisition, development & commercialization of treatments for B-cell diseases.
8K Followers 3K FollowingCEO Tangram Therapeutics. AI drug discovery and RNAi. Previous life as equity analyst & equity trading . International Master of Chess. Views my own, DYOR.